CME Operating Income vs Income Tax Expense Analysis
CME Stock | USD 216.77 1.29 0.60% |
CME financial indicator trend analysis is way more than just evaluating CME Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CME Group is a good investment. Please check the relationship between CME Operating Income and its Income Tax Expense accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Operating Income vs Income Tax Expense
Operating Income vs Income Tax Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CME Group Operating Income account and Income Tax Expense. At this time, the significance of the direction appears to have very week relationship.
The correlation between CME's Operating Income and Income Tax Expense is 0.22. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of CME Group, assuming nothing else is changed. The correlation between historical values of CME's Operating Income and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of CME Group are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Operating Income i.e., CME's Operating Income and Income Tax Expense go up and down completely randomly.
Correlation Coefficient | 0.22 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Operating Income
Operating Income is the amount of profit realized from CME Group operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of CME Group is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Income Tax Expense
Most indicators from CME's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CME Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At present, CME's Enterprise Value is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.9B | 4.3B | 4.5B | 2.5B | Total Revenue | 4.7B | 5.0B | 5.6B | 3.0B |
CME fundamental ratios Correlations
Click cells to compare fundamentals
CME Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CME fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 75.2B | 124.7B | 196.8B | 174.2B | 129.8B | 136.3B | |
Short Long Term Debt Total | 3.7B | 3.4B | 3.4B | 3.4B | 3.9B | 2.4B | |
Other Current Liab | 38.5B | 88.1B | 159.6B | 132.2B | 93.3B | 98.0B | |
Total Current Liabilities | 38.5B | 88.2B | 160.4B | 137.7B | 93.4B | 98.1B | |
Total Stockholder Equity | 26.1B | 26.3B | 27.4B | 26.9B | 26.7B | 17.6B | |
Other Liab | 6.2B | 6.7B | 6.3B | 5.7B | 6.6B | 6.2B | |
Property Plant And Equipment Net | 544M | 579.2M | 505.3M | 455.5M | 681.5M | 483.4M | |
Net Debt | 2.2B | 1.8B | 610.2M | 718.3M | 966.7M | 843.5M | |
Retained Earnings | 5.0B | 5.0B | 5.2B | 4.7B | 4.5B | 3.0B | |
Accounts Payable | 61.9M | 69.3M | 48.8M | 121.4M | 90.6M | 51.7M | |
Cash | 1.6B | 1.6B | 2.8B | 2.7B | 2.9B | 3.1B | |
Non Current Assets Total | 35.6B | 35.4B | 35.0B | 35.1B | 34.8B | 24.0B | |
Non Currrent Assets Other | 2.1B | 2.0B | 3.3B | (3.1B) | 514.1M | 1.0B | |
Other Assets | 545.9M | 7.3B | 3.3B | 574M | 134.4M | 127.7M | |
Long Term Debt | 3.7B | 3.4B | 2.7B | 3.4B | 3.4B | 2.5B | |
Cash And Short Term Investments | 1.6B | 1.7B | 2.9B | 2.8B | 3.0B | 2.7B | |
Net Receivables | 491.8M | 461.3M | 434.5M | 483.2M | 1.3B | 1.3B | |
Common Stock Shares Outstanding | 358.2M | 358.5M | 358.9M | 359.2M | 359.5M | 311.9M | |
Liabilities And Stockholders Equity | 75.2B | 124.7B | 196.8B | 174.2B | 129.8B | 136.3B | |
Non Current Liabilities Total | 10.5B | 10.1B | 9.0B | 9.6B | 9.6B | 7.4B | |
Other Current Assets | 360.1M | 302M | 423M | 524.9M | (4.3B) | (4.1B) | |
Other Stockholder Equity | 21.1B | 21.2B | 22.2B | 22.3B | 22.3B | 14.5B | |
Total Liab | 49.1B | 98.3B | 169.4B | 147.3B | 103.1B | 108.3B | |
Property Plant And Equipment Gross | 544M | 579.2M | 505.3M | 455.5M | 1.3B | 1.4B | |
Total Current Assets | 39.6B | 89.3B | 161.8B | 139.1B | 94.9B | 99.6B | |
Accumulated Other Comprehensive Income | 3.4M | 134.9M | 53.5M | (133.3M) | (55.6M) | (52.8M) | |
Property Plant Equipment | 544M | 579.2M | 505.3M | 837.6M | 963.2M | 490.1M | |
Short Term Investments | 83.2M | 100.9M | 115M | 96M | 111.7M | 106.1M | |
Inventory | 37.1B | 86.8B | 158.0B | 135.3B | 155.5B | 163.3B | |
Short Term Debt | 49.7M | 52.2M | 749.4M | 16M | 55.1M | 52.3M | |
Intangible Assets | 22.3B | 22.0B | 20.7B | 20.4B | 20.2B | 18.4B | |
Good Will | 10.7B | 10.8B | 10.5B | 10.5B | 10.5B | 8.9B | |
Retained Earnings Total Equity | 4.9B | 5.0B | 5.0B | 5.2B | 5.9B | 3.7B | |
Deferred Long Term Liab | 5.7B | 5.6B | 5.6B | 5.4B | 6.2B | 4.7B | |
Net Tangible Assets | (6.9B) | (6.5B) | (3.8B) | (4.0B) | (4.7B) | (4.9B) | |
Long Term Debt Total | 3.8B | 3.7B | 3.4B | 2.7B | 3.1B | 2.9B |
Pair Trading with CME
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CME position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will appreciate offsetting losses from the drop in the long position's value.Moving together with CME Stock
0.83 | ICE | Intercontinental Exchange Financial Report 2nd of May 2024 | PairCorr |
Moving against CME Stock
0.7 | FG | FG Annuities Life Financial Report 1st of May 2024 | PairCorr |
0.68 | DHIL | Diamond Hill Investment | PairCorr |
0.55 | SPGI | SP Global Earnings Call Tomorrow | PairCorr |
0.52 | HG | Hamilton Insurance Report 21st of October 2024 | PairCorr |
0.45 | BY | Byline Bancorp Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to CME could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CME when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CME - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CME Group to buy it.
The correlation of CME is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CME moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CME Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CME can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.276 | Dividend Share 4.4 | Earnings Share 8.86 | Revenue Per Share 15.512 | Quarterly Revenue Growth 0.192 |
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.